ISMP Calls For Hospitals To Employ Medication Safety Officers

A prominent consumer drug safety group is calling on hospitals nationwide to employ medication safety officers, indicating that they would help protect patients from medication errors that result in serious and life-threatening injuries. 

The Institute for Safe Medication Practices (ISMP) issued a white paper (PDF) this month, detailing why it is calling for Medication Safety Officers (MSO) to be a part of hospital healthcare teams. The group indicates that its own assessment of hospital safety suggests that those with facilities with an MSO are better at protecting patients from medication mistakes.

The policy paper notes that the Institute of Medicine, now known as the National Academy of Medicine, found in 2007 that “each of the annual 1.5 million hospitalized patients experience, on average, one medication error a day.” In addition the ISMP notes that more recent data suggests that adverse drug events and medication errors occur in one out of every 20 surgeries and is a major cause of hospital readmissions in older adults.

Did You Know?

Millions of Philips CPAP Machines Recalled

Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.

Learn More

The global cost of medication errors and suboptimal medication use is estimated to be about $500 billion a year.

ISMP indicates that Medication Safety Officers can reduce many of those incidents, as well as generate significant savings for hospitals and patients. The paper notes that this is backed up by data from hospitals where such positions are already in place.

“I have had the opportunity over many years to work closely with our Medication Safety Officers (MSOs). With this collaboration, I have always been impressed by their specialized understanding of the medication-use system and the many medication related error mechanisms encountered in our complex hospital environment,” Johns Hopkins Hospital President Redonda Miller, states in the report. “While it is not possible to calculate the savings associated with their efforts, I have no doubt that our MSOs are a cost effective and valuable asset, and without them, our ongoing patient safety efforts would be at a disadvantage.”

The medication safety officer position is a leadership role designed to coordinate medication safety improvements and strategies for a hospital or healthcare facility. They act as stewards of knowledge on medication safety, develop strategies for improving medication safety in a facility and share and collect medication error reporting data, among other duties.

It is unclear how many such positions are currently in action in U.S. hospitals. The ISMP report notes that there are 189 different titles currently in use for the position here. The position has existed in some hospitals since about 2013, and the United Kingdom made them a requirement at the hospital level in 2014. There are now about 450 Medication Safety Officers in the U.K.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

AT&T Data Breach Lawsuits Seek Damages for 70M Customers Whose Information Was Released
AT&T Data Breach Lawsuits Seek Damages for 70M Customers Whose Information Was Released (Posted today)

AT&T faces a growing number of data breach class action lawsuits, which plaintiffs say should be consolidated before one federal judge for coordinated pretrial proceedings.

Fairness of Philips CPAP Recall Settlement Being Evaluated By MDL Judge
Fairness of Philips CPAP Recall Settlement Being Evaluated By MDL Judge (Posted yesterday)

A federal judge has held a fairness hearing for a proposed Philips CPAP class action lawsuit settlement, which seeks to resolve claims that consumers suffered economic damages due to the massive recall over toxic sound abatement foam.